Education
About Us
Working with TipRanks
Follow Us
Todd Bazemore Insider Profile
11 Followers
Todd Bazemore, EVP & CCO at Dyax Corp, holds 83.70K shares in Kala Pharmaceuticals (Ticker: KALA), holds 0.00 shares in Dyax Corp (Ticker: DYAX), holds ― shares in Pulmatrix (Ticker: PULM).
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
-19.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Todd Bazemore holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Mar 17, 2020 - Mar 17, 2021
Return:+18.50%
The most profitable trade made by Todd Bazemore
Todd Bazemore's Trading History
Dyax Corp
Jan 22, 2016
―
Uninformative Sell
―
$0.00
Kala Pharmaceuticals
Jun 26, 2025
Interim CEO, President and COO
Uninformative Sell
16.27K
$585.90K
Pulmatrix
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Todd Bazemore's performance on stock
You May Also Like
Todd Bazemore insider profile FAQ
What is the percentage of profitable transactions made by Todd Bazemore?
The percentage of profitable transactions made by Todd Bazemore is 33%.
What is the average return per transaction made by Todd Bazemore?
The average return per transaction made by Todd Bazemore is -19.40%.
What stocks does Todd Bazemore hold?
Todd Bazemore holds: DYAX, KALA, PULM stocks.
What was Todd Bazemore’s latest transaction?
Todd Bazemore latest transaction was an Uninformative Sell of $16.27K.
What was Todd Bazemore's most profitable transaction?
Todd Bazemore’s most profitable transaction was an Informative Buy of KALA stock on March 17, 2020. The return on the trade was 18.50%.
What is Todd Bazemore's role in Dyax Corp?
Todd Bazemore's role in Dyax Corp is EVP & CCO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.